234 related articles for article (PubMed ID: 33454822)
61. Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers.
Muñoz-Cobo I; Erburu MM; Zwergel C; Cirilli R; Mai A; Valente S; Puerta E; Tordera RM
Psychopharmacology (Berl); 2018 Oct; 235(10):2831-2846. PubMed ID: 30091005
[TBL] [Abstract][Full Text] [Related]
62. Low level prenatal exposure to methylmercury disrupts neuronal migration in the developing rat cerebral cortex.
Guo BQ; Yan CH; Cai SZ; Yuan XB; Shen XM
Toxicology; 2013 Feb; 304():57-68. PubMed ID: 23220560
[TBL] [Abstract][Full Text] [Related]
63. Effects of foetal and breastfeeding exposure to methylmercury (MeHg) and retinol palmitate (Vitamin A) in rats: Redox parameters and susceptibility to DNA damage in liver.
Rosa-Silva HTD; Panzenhagen AC; Espitia-Pérez P; Teixeira AA; Roitman A; Almeida RF; Heimfarth L; Moreira JCF
Mutat Res Genet Toxicol Environ Mutagen; 2020; 858-860():503239. PubMed ID: 33198929
[TBL] [Abstract][Full Text] [Related]
64. The histone deacetylase inhibitor trichostatin A induces neurite outgrowth in PC12 cells via the epigenetically regulated expression of the nur77 gene.
Tomioka T; Maruoka H; Kawa H; Yamazoe R; Fujiki D; Shimoke K; Ikeuchi T
Neurosci Res; 2014 Nov; 88():39-48. PubMed ID: 25128386
[TBL] [Abstract][Full Text] [Related]
65. An autophagy deficiency promotes methylmercury-induced multinuclear cell formation.
Takanezawa Y; Nakamura R; Sone Y; Uraguchi S; Kiyono M
Biochem Biophys Res Commun; 2019 Apr; 511(2):460-467. PubMed ID: 30797556
[TBL] [Abstract][Full Text] [Related]
66. Effects of histone deacetylase inhibitory prodrugs on epigenetic changes and DNA damage response in tumor and heart of glioblastoma xenograft.
Tarasenko N; Nudelman A; Rozic G; Cutts SM; Rephaeli A
Invest New Drugs; 2017 Aug; 35(4):412-426. PubMed ID: 28315153
[TBL] [Abstract][Full Text] [Related]
67. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
Santini V; Gozzini A; Ferrari G
Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226
[TBL] [Abstract][Full Text] [Related]
68. Histone deacetylase inhibitors stimulate histone H3 lysine 4 methylation in part via transcriptional repression of histone H3 lysine 4 demethylases.
Huang PH; Chen CH; Chou CC; Sargeant AM; Kulp SK; Teng CM; Byrd JC; Chen CS
Mol Pharmacol; 2011 Jan; 79(1):197-206. PubMed ID: 20959362
[TBL] [Abstract][Full Text] [Related]
69. Differential regulation of expression of RNA-editing enzymes, ADAR1 and ADAR2, by 5-aza-2'-deoxycytidine and trichostatin A in human neuronal SH-SY5Y cells.
Uchida H; Ito S
Neuroreport; 2015 Dec; 26(18):1089-94. PubMed ID: 26485095
[TBL] [Abstract][Full Text] [Related]
70. Dual targeting of epigenetic therapy in cancer.
Hellebrekers DM; Griffioen AW; van Engeland M
Biochim Biophys Acta; 2007 Jan; 1775(1):76-91. PubMed ID: 16930846
[TBL] [Abstract][Full Text] [Related]
71. Investigating the effects of in utero benzene exposure on epigenetic modifications in maternal and fetal CD-1 mice.
Philbrook NA; Winn LM
Toxicol Appl Pharmacol; 2015 Nov; 289(1):12-9. PubMed ID: 26341289
[TBL] [Abstract][Full Text] [Related]
72. Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells.
Sundaram MK; Ansari MZ; Al Mutery A; Ashraf M; Nasab R; Rai S; Rais N; Hussain A
Anticancer Agents Med Chem; 2018; 18(3):412-421. PubMed ID: 28925878
[TBL] [Abstract][Full Text] [Related]
73. Methylmercury disruption of embryonic neural development in Drosophila.
Rand MD; Dao JC; Clason TA
Neurotoxicology; 2009 Sep; 30(5):794-802. PubMed ID: 19409416
[TBL] [Abstract][Full Text] [Related]
74. Cerebral gene expression in response to single or combined gestational exposure to methylmercury and selenium through the maternal diet.
Jayashankar S; Glover CN; Folven KI; Brattelid T; Hogstrand C; Lundebye AK
Cell Biol Toxicol; 2011 Jun; 27(3):181-97. PubMed ID: 21240674
[TBL] [Abstract][Full Text] [Related]
75. The histone deacetylase complex MiDAC regulates a neurodevelopmental gene expression program to control neurite outgrowth.
Mondal B; Jin H; Kallappagoudar S; Sedkov Y; Martinez T; Sentmanat MF; Poet GJ; Li C; Fan Y; Pruett-Miller SM; Herz HM
Elife; 2020 Apr; 9():. PubMed ID: 32297854
[TBL] [Abstract][Full Text] [Related]
76. Methylmercury Affects the Expression of Hypothalamic Neuropeptides That Control Body Weight in C57BL/6J Mice.
Ferrer B; Peres TV; Dos Santos AA; Bornhorst J; Morcillo P; Gonçalves CL; Aschner M
Toxicol Sci; 2018 Jun; 163(2):557-568. PubMed ID: 29850906
[TBL] [Abstract][Full Text] [Related]
77. Developmental exposure to 50 parts-per-billion arsenic influences histone modifications and associated epigenetic machinery in a region- and sex-specific manner in the adult mouse brain.
Tyler CR; Hafez AK; Solomon ER; Allan AM
Toxicol Appl Pharmacol; 2015 Oct; 288(1):40-51. PubMed ID: 26193056
[TBL] [Abstract][Full Text] [Related]
78. Postnatal Ethanol Exposure Activates HDAC-Mediated Histone Deacetylation, Impairs Synaptic Plasticity Gene Expression and Behavior in Mice.
Shivakumar M; Subbanna S; Joshi V; Basavarajappa BS
Int J Neuropsychopharmacol; 2020 May; 23(5):324-338. PubMed ID: 32170298
[TBL] [Abstract][Full Text] [Related]
79. Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension.
Chen F; Li X; Aquadro E; Haigh S; Zhou J; Stepp DW; Weintraub NL; Barman SA; Fulton DJR
Free Radic Biol Med; 2016 Oct; 99():167-178. PubMed ID: 27498117
[TBL] [Abstract][Full Text] [Related]
80. Epigenetic therapies in patients with solid tumors: Focus on monotherapy with deoxyribonucleic acid methyltransferase inhibitors and histone deacetylase inhibitors.
Katarzyna R; Lucyna B
J Cancer Res Ther; 2019; 15(5):961-970. PubMed ID: 31603095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
